Search results for "From ACP Internist Weekly"


 
Results 21 - 30 of about 60 for "From ACP Internist Weekly".

Lifestyle modification may outperform medications over time for diabetes prevention, meta-analysis finds | ACP Diabetes Monthly

Twenty-five people would need to be treated with lifestyle modification to prevent one diabetes case, according to the analysis of randomized clinical trials that evaluated lifestyle modification and medication interventions for diabetes prevention

November 14, 2014 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Score may help predict which patients are likely to achieve type 2 diabetes cure after bariatric surgery | ACP Diabetes Monthly

DiaRem, a weighted score ranging from 0 to 22 points, is based on age, insulin dependence, diabetes medication use, and HbA1c level.

Aspirin primary prevention trial in Japan halted for lack of mortality benefit | ACP Diabetes Monthly

Low-dose aspirin for primary prevention reduced nonfatal myocardial infarction, but not death from cardiovascular causes, in older Japanese patients, a recent study found.

January 11, 2019 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

December 12, 2014 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Primary care-based weight-loss program led to remission of type 2 diabetes | ACP Diabetes Monthly

At the end of 12 months, 36 intervention participants lost 15 kg or more, compared to no participants in the control group, and diabetes remission was associated with the amount of weight lost.

GLP-1 analogues may be associated with bile duct, gallbladder disease | ACP Diabetes Monthly

Current use of DPP-4 inhibitors was not associated with increased risk for bile duct and gallbladder disease versus current use of at least 2 oral antidiabetic drugs, but an increased risk was seen with use of GLP-1 analogues.

May 12, 2017 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Physician volume linked to diabetes care quality, study finds | ACP Diabetes Monthly

The researchers found that higher ambulatory volume overall was associated with lower rates of appropriate eye exams, HbA1c testing, and LDL cholesterol testing, but higher diabetes-specific volume was associated with better care according to

Result Page: Prev   1   2   3   4   5   6   Next